🇺🇸 FDA
Patent

US 12409197

Synergistic bacterial compositions and methods of production and use thereof

granted A61KA61K2035/11A61K2035/115

Quick answer

US patent 12409197 (Synergistic bacterial compositions and methods of production and use thereof) held by Seres Therapeutics, Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2035/11, A61K2035/115, A61K35/74, A61K35/742